Cargando…
A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors
HER4 is a receptor tyrosine kinase that is required for the evolution of normal body systems such as cardiovascular, nervous, and endocrine systems, especially the mammary glands. It is activated through ligand binding and activates MAPKs and PI3K/AKT pathways. HER4 is commonly expressed in many hum...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659013/ https://www.ncbi.nlm.nih.gov/pubmed/34885957 http://dx.doi.org/10.3390/molecules26237376 |
_version_ | 1784612865160773632 |
---|---|
author | El-Gamal, Mohammed I. Mewafi, Nada H. Abdelmotteleb, Nada E. Emara, Minnatullah A. Tarazi, Hamadeh Sbenati, Rawan M. Madkour, Moustafa M. Zaraei, Seyed-Omar Shahin, Afnan I. Anbar, Hanan S. |
author_facet | El-Gamal, Mohammed I. Mewafi, Nada H. Abdelmotteleb, Nada E. Emara, Minnatullah A. Tarazi, Hamadeh Sbenati, Rawan M. Madkour, Moustafa M. Zaraei, Seyed-Omar Shahin, Afnan I. Anbar, Hanan S. |
author_sort | El-Gamal, Mohammed I. |
collection | PubMed |
description | HER4 is a receptor tyrosine kinase that is required for the evolution of normal body systems such as cardiovascular, nervous, and endocrine systems, especially the mammary glands. It is activated through ligand binding and activates MAPKs and PI3K/AKT pathways. HER4 is commonly expressed in many human tissues, both adult and fetal. It is important to understand the role of HER4 in the treatment of many disorders. Many studies were also conducted on the role of HER4 in tumors and its tumor suppressor function. Mostly, overexpression of HER4 kinase results in cancer development. In the present article, we reviewed the structure, location, ligands, physiological functions of HER4, and its relationship to different cancer types. HER4 inhibitors reported mainly from 2016 to the present were reviewed as well. |
format | Online Article Text |
id | pubmed-8659013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86590132021-12-10 A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors El-Gamal, Mohammed I. Mewafi, Nada H. Abdelmotteleb, Nada E. Emara, Minnatullah A. Tarazi, Hamadeh Sbenati, Rawan M. Madkour, Moustafa M. Zaraei, Seyed-Omar Shahin, Afnan I. Anbar, Hanan S. Molecules Review HER4 is a receptor tyrosine kinase that is required for the evolution of normal body systems such as cardiovascular, nervous, and endocrine systems, especially the mammary glands. It is activated through ligand binding and activates MAPKs and PI3K/AKT pathways. HER4 is commonly expressed in many human tissues, both adult and fetal. It is important to understand the role of HER4 in the treatment of many disorders. Many studies were also conducted on the role of HER4 in tumors and its tumor suppressor function. Mostly, overexpression of HER4 kinase results in cancer development. In the present article, we reviewed the structure, location, ligands, physiological functions of HER4, and its relationship to different cancer types. HER4 inhibitors reported mainly from 2016 to the present were reviewed as well. MDPI 2021-12-05 /pmc/articles/PMC8659013/ /pubmed/34885957 http://dx.doi.org/10.3390/molecules26237376 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review El-Gamal, Mohammed I. Mewafi, Nada H. Abdelmotteleb, Nada E. Emara, Minnatullah A. Tarazi, Hamadeh Sbenati, Rawan M. Madkour, Moustafa M. Zaraei, Seyed-Omar Shahin, Afnan I. Anbar, Hanan S. A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors |
title | A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors |
title_full | A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors |
title_fullStr | A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors |
title_full_unstemmed | A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors |
title_short | A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors |
title_sort | review of her4 (erbb4) kinase, its impact on cancer, and its inhibitors |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659013/ https://www.ncbi.nlm.nih.gov/pubmed/34885957 http://dx.doi.org/10.3390/molecules26237376 |
work_keys_str_mv | AT elgamalmohammedi areviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT mewafinadah areviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT abdelmottelebnadae areviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT emaraminnatullaha areviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT tarazihamadeh areviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT sbenatirawanm areviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT madkourmoustafam areviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT zaraeiseyedomar areviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT shahinafnani areviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT anbarhanans areviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT elgamalmohammedi reviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT mewafinadah reviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT abdelmottelebnadae reviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT emaraminnatullaha reviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT tarazihamadeh reviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT sbenatirawanm reviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT madkourmoustafam reviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT zaraeiseyedomar reviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT shahinafnani reviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors AT anbarhanans reviewofher4erbb4kinaseitsimpactoncanceranditsinhibitors |